Developments in nanotechnology mean that engineered nanoparticles (ENPs) are found in increasingly large quantities on the European market. To manage any potential human health hazards, comprehensive risk-assessment tools and protocols are required. A novel model for the human health assessment of ENPs has been developed that ranks ENPs by risk, enabling the prioritisation of the most potentially hazardous ENPs in Europe. Click here to read more